News | Ultrasound Imaging | June 01, 2021

Placental bulge sign on prenatal ultrasound or MRI helps diagnose severe placental accreta spectrum disorder warranting hysterectomy rather than conservative management

A) Ultrasound in 28-year-old woman (B) MRI in 34-year-old woman with suspected PAS disorder. Focal area of placental tissues bulge toward imaginary lines of normal uterine contour (dash lines). Length (L) and depth (D) measurements of placental bulge also demonstrated. p = placenta; b = bladder. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

A) Ultrasound in 28-year-old woman (B) MRI in 34-year-old woman with suspected PAS disorder. Focal area of placental tissues bulge toward imaginary lines of normal uterine contour (dash lines). Length (L) and depth (D) measurements of placental bulge also demonstrated. p = placenta; b = bladder. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)


June 1, 2021 — According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), accurate prenatal diagnosis of severe placental accreta spectrum (PAS) disorder by imaging could help guide maternal counseling and selection between hysterectomy and uterine-preserving surgery.

"The findings suggest strong performance of placental bulge in diagnosing severe PAS on both ultrasound and MRI, with potentially relatively stronger performance on MRI," wrote corresponding author Manjiri Dighe from the department of radiology at the University of Washington School of Medicine. "Nonetheless, interobserver agreement remains suboptimal on both modalities."

On ultrasound and MRI alike, the placental bulge sign represents deeper venous invasion in PAS—the focal area of myometrial-placental bulging beyond the normal uterine contour. Dighe and colleagues' retrospective study included 62 pregnant women (mean age, 33.2 years) with clinically suspected PAS who underwent both ultrasound and MRI. Blinded to final diagnoses, two maternal-fetal medicine specialists for ultrasound and three abdominal radiologists for MRI independently reviewed images for their respective modality. Using intraoperative and pathologic findings, alongside International Federation of Gynaecology and Obstetrics classification, patients were separated into those with and without severe PAS.

"In diagnosing severe PAS," Dighe et al. noted, "placental bulge sign achieved on ultrasound an accuracy of 85.5%, sensitivity of 91.7%, and specificity of 76.9%, and on MRI an accuracy of 90.3%, sensitivity of 94.4%, and specificity of 84.6%." Ultimately, placental bulge was an independent predictor of severe PAS on ultrasound (odds ratio=8.94) and MRI (odds ratio=45.67).

"Placental bulge sign on either prenatal ultrasound or MRI may help diagnose severe PAS warranting hysterectomy rather than conservative management," the authors of this AJR article concluded.

For more information: www.arrs.org


Related Content

News | Computed Tomography (CT)

Jan. 21, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) cleared the industry's first ...

Time January 23, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
News | PACS

Jan. 21, 2026 — Fujifilm Healthcare Americas Corp. and Voicebrook, Inc. have announced a strategic partnership to ...

Time January 22, 2026
arrow
News | Radiology Education

Jan. 20, 2026 — The American Society of Radiologic Technicians (ASRT) Foundation has named ASRT member Danielle McDonagh ...

Time January 20, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Radiology Business

Jan. 7, 2026 — RadNet, Inc., a provider of high-quality, cost-effective outpatient diagnostic imaging services and ...

Time January 13, 2026
arrow
News | X-Ray

Dec. 31, 2025 – Carestream Health, Inc. has completed the separation of the company into two geographically focused ...

Time January 08, 2026
arrow
Subscribe Now